Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00243919 · ClinicalTrials.gov registry record · Phase 3
Locomotor Experience Applied Post Stroke Trial
A Phase 3 study of Stroke, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 408
- Enrollment target
- 8
- Study locations
NCT00243919: Completed Phase 3 study of Stroke, sponsored by Duke University.
NCT00243919 is a Phase 3 study of Stroke that has completed, run by Duke University. The registered enrollment target is 408 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower). The trial reports 8 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00243919, a Phase 3 study of Stroke, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 408 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).
Primary Outcome
Success: walking greater than 0.4 m/sec if baseline was less than 0.4; walking greater than 0.8 m/sec if baseline was 0.4m/sec or greater but less than 0.8 m/sec as measured during 10 meter walk.
Conditions Studied
Interventions
- BEHAVIORAL Home Exercise Program
- BEHAVIORAL Early locomotor training program
- BEHAVIORAL Late locomotor training program
Study Locations (8)
California
- Centinela Freeman Memorial Hospital - Inglewood
- Long Beach Memorial Hospital - Long Beach
- University of Southern California - PT Associates - Los Angeles
- Sharp Memorial Rehabilitation Center - San Diego
Florida
- University of Florida - Gainesville
- Brooks Rehabilitation Hospital - Jacksonville
- Florida Hospital - Orlando
North Carolina
- Duke University (Administrative Coordinating Center) - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
What the finished NCT00243919 record still lists
NCT00243919 is an interventional study that assigns participants to a tested intervention. The registered 408 participants enrollment target is mid-sized for trials with a published cap, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Home Exercise Program is the first listed.
NCT00243919 lists 8 locations in 3 states (California, Florida, North Carolina).
Frequently Asked Questions
What is clinical trial NCT00243919 about?
NCT00243919 is a clinical study titled "Locomotor Experience Applied Post Stroke Trial". The purpose of this study is to compare two different treatments to improve walking after stroke (or post-stroke).
What is the current status of trial NCT00243919?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 408 participants. The study started on 2006-04. Estimated completion is 2012-06.
What conditions does trial NCT00243919 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT00243919?
The interventions under investigation include: Home Exercise Program (BEHAVIORAL), Early locomotor training program (BEHAVIORAL), Late locomotor training program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00243919?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00243919 being conducted?
This trial has 8 study locations across California, Florida, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00243919's enrollment target sits among peer trials
408 64th of 454 higher than 391 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RECRUITING · Phase 3
-
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
ACTIVE NOT RECRUITING · Phase 3
-
Vitamin Therapy for Prevention of Stroke
COMPLETED · Phase 3
-
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
COMPLETED · Phase 3
-
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
COMPLETED · Phase 3
-
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04835428 · 408 participants · NA
STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures
- NCT05836324 · 408 participants · Phase 1
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- NCT05863195 · 408 participants · Phase 3
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- NCT06612268 · 408 participants · Phase 3
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia